Elevated levels of ΔFosB and RGS9 in striatum in Parkinson’s disease
- 15 November 2001
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 50 (10) , 813-816
- https://doi.org/10.1016/s0006-3223(01)01234-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dopamine-receptor stimulation: biobehavioral and biochemical consequencesTrends in Neurosciences, 2000
- Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's DiseaseNeurobiology of Disease, 1999
- Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-DOPA treatmentNeuroscience, 1999
- Region-specific induction of ?FosB by repeated administration of typical versus atypical antipsychotic drugsSynapse, 1999
- Mammalian RGS Proteins: Barbarians at the GateJournal of Biological Chemistry, 1998
- D1-receptor-related priming is attenuated by antisense-meditated `knockdown' of fosB expressionMolecular Brain Research, 1998
- Regulators of G-Protein Signaling (RGS) Proteins: Region-Specific Expression of Nine Subtypes in Rat BrainJournal of Neuroscience, 1997
- Fos B mutant mice: Loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine’s psychomotor and rewarding effectsProceedings of the National Academy of Sciences, 1997
- Chronic Alterations in Dopaminergic Neurotransmission Produce a Persistent Elevation of ΔFosB‐like Protein(s) in both the Rodent and Primate StriatumEuropean Journal of Neuroscience, 1996
- Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeysBrain Research, 1986